Testican-2 Is Associated with Reduced Risk of Incident ESKD : Journal of the American Society of Nephrology

Journal Logo

Clinical Research: Chronic Kidney Disease

Testican-2 Is Associated with Reduced Risk of Incident ESKD

Wen, Donghai1,2; Zhou, Linda3; Zheng, Zihe4; Surapaneni, Aditya3; Ballantyne, Christie M.5; Hoogeveen, Ron C.5; Shlipak, Michael G.6,7; Waikar, Sushrut S.8; Vasan, Ramachandran S.9,10; Kimmel, Paul L.11; Dubin, Ruth F.12; Deo, Rajat13; Feldman, Harold I.4; Ganz, Peter14; Coresh, Josef3; Grams, Morgan E.3,15; Rhee, Eugene P.1,2;  on behalf of the CKD Biomarkers Consortium

Author Information
Journal of the American Society of Nephrology 34(1):p 122-131, January 2023. | DOI: 10.1681/ASN.2022020216
  • Buy
  • Infographic

Abstract

Copyright © 2022 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid